Trial Details
WITHDRAWNBasic Information
| Clinical ID | c2823 |
|---|---|
| Identifier | NCT02913508 |
| Trial Title | Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab intravenous injection|DRUG: Vedolizumab subcutaneous injection |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2014-04 |
|---|---|
| Primary Completion Date | 2015-12 |
| Completion Date | 2015-12 |